Raptor Pharmaceuticals Corp (RPTP)

HEALTH CARE: HEALTH CARE
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

11085 NORTH TORREY PINES ROAD LA JOLLA, CA 92037

Operates as a biopharmaceutical company that engages in the acquisition and development of proprietary pharmaceutical compounds for the treatment of Central Nervous System disorders.

View SEC Filings from RPTP instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RPTP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RPTP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANDERSON RAYMOND

  • Director
No longer subject to file 2016-10-24 0

BRUHN SUZANNE LOUISE

  • Director
No longer subject to file 2016-10-24 0

FRANKLIN RICHARD L

  • Director
No longer subject to file 2016-10-24 0

KELTNER LLEW

  • Director
No longer subject to file 2016-10-24 0

STARR CHRISTOPHER M

  • Director
No longer subject to file 2016-10-24 0

SMITH JULIE PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2016-10-24 0

HAPPEL DAVID CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2016-10-24 0

GEMAYEL GEORGES

  • Director
No longer subject to file 2016-10-24 0

LAPOINTE ANTHONY GREGG

  • Director
No longer subject to file 2016-10-24 0

SMITH MICHAEL P CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2016-10-24 0

POLU KRISHNA R CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2016-10-24 0

GOULD ASHLEY C. CHIEF LEGAL OFFICER

  • Officer
No longer subject to file 2016-10-24 0

DALEY THOMAS E CHIEF BUSINESS OFFICER

  • Officer
34,719 2015-06-18 0

SAGER ERICH

  • Director
4,005 2015-03-05 0

LANZA FRANK J

  • PRINCIPAL FINANCIAL OFFICER
0 2014-10-23 0

ERBEZ GEORGIA CHIEF FINANCIAL OFFICER

  • Officer
19,600 2014-05-13 0

SAMANT VIJAY B

  • Director
0 2014-04-07 0

WALBERT TIMOTHY P

  • Director
0 2014-03-13 0

HYPERION TRADING SEGREGATED PORTFOLIO

  • 10% Owner
No longer subject to file 2013-08-14 0

POWELL KATHLENE LINN

  • CQO, RAPTOR THERAPEUTICS
No longer subject to file 2012-09-25 0

REICHENBERGER MARC PATRICK

  • VP COMM OPS, RAPTOR THERA
No longer subject to file 2012-09-25 0

RIOUX PATRICE

  • CMO, RAPTOR THERAPEUTICS
No longer subject to file 2012-09-25 0

ZANKEL TODD CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2012-09-25 0

TSUCHIMOTO KIM R

  • VICE PRESIDENT FINANCE
No longer subject to file 2012-09-25 0

DOUDE VAN TROOSTWIJK HENK J

  • GEN MGR EUROPEAN COMMOP
No longer subject to file 2012-09-25 0

GIMV NV

ADVIESBEHEER GIMV LIFE SCIENCES NV

BIOTECH FONDS VLAANDEREN NV

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2009-09-17 0

ALTA PARTNERS

DELEAGE JEAN

ALTA CALIFORNIA PARTNERS II LP

ALTA CALIFORNIA MANAGEMENT PARTNERS II LLC

ALTA EMBARCADERO PARTNERS II LLC

ALTA CALIFORNIA PARTNERS II, L.P. -- NEW POOL

ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC -- NEW POOL

NOHRA GUY P

JANNEY DANIEL

GRUENER GARRETT

  • FORMER 10% OWNERNOT DIRECTOR OR 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNER
No longer subject to file 2009-09-03 0

ALTA PARTNERS III, INC.

ALTA BIOPHARMA PARTNERS III LP

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

DELEAGE JEAN

CHAMPSI FARAH

PENHOET EDWARD

HURWITZ EDWARD

  • FORMER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNOT DIRECTOR OR 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNER
No longer subject to file 2009-09-03 0

GRAHAM EVELYN A CHIEF EXECUTIVE OFFICER

  • Officer
0 2009-02-03 0

JOHNSON CRAIG A V.P. FINANCE, CFO & SECRETARY

  • Officer
0 2009-02-03 0

SCHNEIDER PAUL R V.P. AND GENERAL COUNSEL

  • Officer
0 2009-02-03 0

DAVIS PETER PHD

  • Director
0 2008-06-19 0

FERRIS STEVEN H

  • Director
0 2008-06-19 0

DELEAGE JEAN

  • Director
0 2008-06-19 0

RATOFF STEVEN B

  • Director
0 2008-06-19 0

FISHERMAN JASON S

  • Director
0 2008-06-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments